Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 46.47B |
| Enterprise Value | 70.02B |
| P/E Ratio | 17.23 |
| PEG Ratio | 2.37 |
| Price/Sales Ratio | 1.43 |
| Price/Book Ratio | 1.2 |
| Enterprise/Revenue | 2.09 |
| Enterprise/EBITDA | 16.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 40.42B |
| Revenue/Share | 16.19 |
| Gross Profit | 20.16B |
| EBITDA | 6.05B |
| Net Income | 3.28B |
| Diluted EPS | 1.24 |
Balance Sheet
| Total Cash | 15.76B |
| Total Cash/Share | 5.97 |
| Total Debt | 33.71B |
| Total Debt/Equity | 0.82 |
| Current Ratio | 0.98 |
| Book Value Per Share | 25.04 |
Price History
| 52-Week Change | -26.62 |
| 52-Week High | 23.5 |
| 52-Week Low | 14.9 |
| Moving Average 50 Days | 17.13 |
| Moving Average 200 Days | 17.96 |
Statistics
| Average Volume | 3.76M |
| Shares Outstanding | 3.75B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.39 |
| Trailing Annual Dividend Yield | 1.7 |
| Payout Ratio | 0.31 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
